NEW YORK (360Dx) – French diagnostic and theranostics firm Theradiag announced on Wednesday that it has signed an agreement to supply its Lisa Tracker monitoring kits for use in monitoring responses to biosimilar drugs sold by French generic drug maker Biogaran.
Lisa Tracker kits are designed to monitor serum levels of circulating TNF-alpha, prescribed TNA-alpha inhibitors, and drug-neutralizing antibodies to help physicians manage treatment regimens.